The Protein Kinase C Signaling Pathway Regulates a Molecular Switch between Transactivation and Transrepression Activity of the Peroxisome Proliferator-Activated Receptor α-Reference-Cited by-同舟云学术

The Protein Kinase C Signaling Pathway Regulates a Molecular Switch between Transactivation and Transrepression Activity of the Peroxisome Proliferator-Activated Receptor α

Published:2004-08-01 Issue:8 Volume:18 Page:1906-1918
ISSN:0888-8809
Container-title:Molecular Endocrinology
language:en
Short-container-title:

Author:

Blanquart Christophe¹,Mansouri Roxane¹,Paumelle Réjane¹,Fruchart Jean-Charles¹,Staels Bart¹,Glineur Corine¹

Affiliation:

1. Institut National de la Santé et de la Recherche Médicale, Unité de Recherche 545, Département d’Athérosclérose, Institut Pasteur de Lille, 59019 Lille, and Faculté de Pharmacie, Université de Lille II, 59000 Lille, France

Publisher

The Endocrine Society

Subject

Endocrinology,Molecular Biology,General Medicine

Link

http://academic.oup.com/mend/article-pdf/18/8/1906/8967594/mend1906.pdf

Reference36 articles.

1. Differential expression of peroxisome proliferator-activated receptor-α, -β, and -γ during rat embryonic development.;Braissant;Endocrinology,1998

2. PPAR agonists as direct modulators of the vessel wall in cardiovascular disease.;Buchan;Med Res Rev,2000

3. Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors.;Kliewer;Nature,1992

4. The mouse peroxisome proliferator activated receptor recognizes a response element in the 5′ flanking sequence of the rat acyl CoA oxidase gene.;Tugwood;EMBO J,1992

5. The PPARs: from orphan receptors to drug discovery.;Willson;J Med Chem,2000

Cited by 89 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hyodeoxycholic acid ameliorates nonalcoholic fatty liver disease by inhibiting RAN-mediated PPARα nucleus-cytoplasm shuttling;Nature Communications;2023-09-06

2. Deoxyelephantopin—a novel PPARγ agonist regresses pressure overload-induced cardiac fibrosis via IL-6/STAT-3 pathway in crosstalk with PKCδ;European Journal of Pharmacology;2023-08

3. PPARα: An emerging target of metabolic syndrome, neurodegenerative and cardiovascular diseases;Frontiers in Endocrinology;2022-12-16

4. Mechanistic insights into the peroxisome proliferator-activated receptor alpha as a transcriptional suppressor;Frontiers in Medicine;2022-11-25

5. The Structure Basis of Phytochemicals as Metabolic Signals for Combating Obesity;Frontiers in Nutrition;2022-06-13